EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
View Top Employees from EyeBioWebsite | https://eyebiotech.com/ |
Employees | 30 (10 on RocketReach) |
Founded | 2021 |
Industry | Biotechnology Research |
Looking for a particular EyeBio employee's phone or email?
David Guyer is the CEO of EyeBio.
10 people are employed at EyeBio.
EyeBio is based in London, England.